PSQH earnings analysis
What we found in PSQH's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
PSQH delivered strong Q2 Financial Technology revenue growth of 108% year over year to $7.13 million, supported by a 153% increase in PSQ Payments GMV, and narrowed its GAAP operating loss to $4.79 million. Sequentially, revenue decreased from approximately $8.16 million in Q1, although gross and operating margins improved; the reported EPS loss was $1.44 versus the $0.09 consensus loss estimate. Cash burn improved, but cash fell to $6.7 million, the company remains loss-making, the EveryLife sale has not closed, and its $17.3 million market capitalization is close to the NYSE's $15.0 million immediate-delisting threshold.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue more than doubled year over year
- Q2 Financial Technology revenue was $7,132,526, up $3,700,650, or 108%, from $3,431,876 a year earlier. Revenue declined sequentially from the prior quarter's approximately $8.16 million implied by the filing's six-month revenue of $15,290,943.
- Operating loss and sequential margin improved
- GAAP operating loss narrowed 8% year over year to $4,789,771 from $5,202,261. Operating margin improved to -67.2% from approximately -151.6% a year ago and from -75.2% in Q1 2026, while gross margin was 58.0%, up from 55.9% sequentially but down from approximately 69.5% a year ago.
- Payments volume accelerated sharply
- PSQ Payments GMV rose 153% year over year to $172,549,029, while Credit GMV increased 32% to $14,102,709. Management attributes Payments growth primarily to more active processing merchants and Credit growth to better conversion and approval rates, a milder seasonal decline, and customer re-engagement.
- Non-GAAP operating result turned positive
- Non-GAAP operating income was $381,400, compared with a $2,729,743 non-GAAP operating loss a year earlier. The improvement reflects stronger scale and lower sales and marketing expense, which declined $672,973, or 44%, to $867,354.
- Cash burn and cost base improved
- Six-month operating cash use improved by $4,813,283 to $6,472,273, versus $11,285,556 a year earlier. The company reduced FTEs to 36 from 72 and reports $9.9 million of savings achieved as of June 30, 2026.
- EveryLife sale could bolster liquidity
- The planned EveryLife asset sale carries a $5.5 million cash purchase price before fees and adjustments and is expected to close by September 30, 2026. This would supplement June 30 unrestricted cash and equivalents of $6.7 million.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Growth carries substantial transaction costs
- Gross margin compressed year over year to 58.0% as cost of revenue increased 186% to $2,998,624, outpacing the 108% increase in revenue. Management cites higher transaction fees from the PSQ Payments and PSQ Impact launches.
- Continuing losses and higher interest burden
- The company remained deeply loss-making, with a Q2 net loss of $5,621,091 and a continuing-operations loss of $5,243,305. Interest expense increased 12% to $974,193.
- Cash and working capital declined
- Liquidity fell materially: unrestricted cash and equivalents declined to $6.7 million at June 30, 2026 from $14.6 million at December 31, 2025, while net working capital fell to $7.5 million from $16.1 million. Six-month investing cash use was $2,712,513, including $1.2 million of software-development costs.
- NYSE market-cap delisting threshold is close
- The updated NYSE risk factor says immediate suspension and delisting procedures apply if 30-day average market capitalization falls below $15.0 million. Average market capitalization was only $17.3 million as of July 31, 2026, leaving a $2.3 million cushion.
- EveryLife sale proceeds are not assured
- The new EveryLife-disposition risk factor notes the $5.5 million sale is subject to closing conditions, purchase-price adjustments and indemnification holdbacks; a delay, failure to close, or lower proceeds would reduce liquidity. The expected closing date is September 30, 2026.
- Payments GMV has high merchant concentration
- PSQ Payments volume is concentrated: its top three merchants represented approximately 83% of Q2 GMV, and the largest merchant represented 35% of the $172,549,029 total. Loss of a major merchant could materially affect processing volume and revenue.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $-1.44
- Gross margin
- 58.0%
- Operating margin
- -67.2%
- Segment
- Financial Technology revenue: $7,132,526
What they said about what is next.
The 10-Q provides no explicit quantitative revenue or EPS guidance. Management expects its planned EveryLife asset sale for $5.5 million in cash to close by September 30, 2026, subject to conditions, and says executed/planned cost actions are expected to generate approximately $8.0 million of annualized cash savings; it also states that the timing and magnitude of cash inflows from merchant agreements may vary.
The filing reads worse than the one before it.
What came before.
- 10-Q · May 7, 2026
- PSQ Holdings, Inc. reported a significant increase in revenue in Q1 2026, totaling $8.16 million, representing a year-over-year growth of 167% compared to $3.05 million in Q1 2025. However, the company logged a higher…
- 10-K · April 30, 2026
- PSQ Holdings, Inc. reported Q4 revenue of $7.33 million, significantly up from $4 million in the prior year, and GAAP diluted EPS improvement to -$0.15 from -$0.59 year-over-year. Amid a positive revenue trajectory,…
- 10-K · March 17, 2026
- PSQ Holdings (PSQH) completed a strategic refocus in 2025 to operate under a single reportable segment—Financial Technology—comprising Credova, PSQ Payments and PSQ Impact, and wound down its Marketplace business as of…
- 10-Q · November 6, 2025
- PSQ Holdings reported Q3 2025 revenue of $4,404,861, up $1,197,453 or 37.3% versus Q3 2024 ($3,207,408). Gross margin compressed to ~67.1% from 96.7% a year ago; operating loss narrowed to $(9,696,099) and GAAP EPS…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing PSQH makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever